Jaguar Health targets mid-2027 MVID NDA filing with possible end-2027 U.S. approval, backed by up to 48% parenteral support reductions — See source for full details.
$JAGX
Price history, market instrument context, member research, and related headlines in one place.
JAGX key statistics
NasdaqCMUSD
52-week range
$2.350%$1,160.25
Latest session $3.94–$4.65Jaguar Health, Inc. (JAGX) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $3.82, down $0.77 (16.68%) from the previous close of $4.59. It has traded between $3.94 and $4.65 in the latest session. Over the past year it has ranged from $2.35 to $1,160.25, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 418.2K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $JAGX research…